Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · IEX Real-Time Price · USD
25.61
+0.39 (1.55%)
At close: Apr 19, 2024, 4:00 PM
26.00
+0.39 (1.52%)
After-hours: Apr 19, 2024, 5:19 PM EDT
Protagonist Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for PTGX stock have an average target of 38.6, with a low estimate of 35 and a high estimate of 42. The average target predicts an increase of 50.72% from the current stock price of 25.61.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 11, 2024.
Analyst Ratings
The average analyst rating for PTGX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 | Strong Buy | Maintains | $38 | +48.38% | Mar 11, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $42 | Buy | Reiterates | $42 | +64.00% | Mar 11, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $34 → $37 | Buy | Maintains | $34 → $37 | +44.47% | Feb 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +48.38% | Feb 28, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $35 → $37 | Buy | Maintains | $35 → $37 | +44.47% | Nov 3, 2023 |
Financial Forecast
Revenue This Year
155.55M
from 60.00M
Increased by 159.25%
Revenue Next Year
140.25M
from 155.55M
Decreased by -9.84%
EPS This Year
0.77
from -1.39
EPS Next Year
-0.82
from 0.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 315.0M | 346.5M | 618.5M | 485.2M | 806.1M |
| Avg | 155.6M | 140.3M | 315.1M | 213.4M | 397.9M |
| Low | n/a | n/a | 77.0M | 58.6M | 158.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 425.0% | 122.8% | 341.0% | 54.0% | 277.7% |
| Avg | 159.3% | -9.8% | 124.7% | -32.3% | 86.4% |
| Low | - | - | -45.1% | -81.4% | -25.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.61 | 2.25 | 0.89 | 2.34 | 5.66 |
| Avg | 0.77 | -0.82 | -1.50 | 0.44 | 2.26 |
| Low | -2.65 | -3.21 | -3.41 | -1.33 | -0.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 193.5% | - | - | 1,175.5% |
| Avg | - | - | - | - | 410.3% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.